494 related articles for article (PubMed ID: 7890645)
1. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease.
Strongin AY; Collier I; Bannikov G; Marmer BL; Grant GA; Goldberg GI
J Biol Chem; 1995 Mar; 270(10):5331-8. PubMed ID: 7890645
[TBL] [Abstract][Full Text] [Related]
2. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.
Strongin AY; Marmer BL; Grant GA; Goldberg GI
J Biol Chem; 1993 Jul; 268(19):14033-9. PubMed ID: 8314771
[TBL] [Abstract][Full Text] [Related]
3. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.
Goldberg GI; Strongin A; Collier IE; Genrich LT; Marmer BL
J Biol Chem; 1992 Mar; 267(7):4583-91. PubMed ID: 1311314
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K; Lohi J; Valtanen H; Keski-Oja J
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
Okada Y; Gonoji Y; Naka K; Tomita K; Nakanishi I; Iwata K; Yamashita K; Hayakawa T
J Biol Chem; 1992 Oct; 267(30):21712-9. PubMed ID: 1400481
[TBL] [Abstract][Full Text] [Related]
6. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
[TBL] [Abstract][Full Text] [Related]
7. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
Bernardo MM; Fridman R
Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
[TBL] [Abstract][Full Text] [Related]
8. Mosaic structure of the secreted ECM metalloproteases and interaction of the type IV collagenases with inhibitors.
Goldberg GI; Collier IE; Eisen AZ; Grant GA; Marmer BL; Wilhelm SM
Matrix Suppl; 1992; 1():25-30. PubMed ID: 1336109
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
[TBL] [Abstract][Full Text] [Related]
10. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
[TBL] [Abstract][Full Text] [Related]
11. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
12. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of human collagenase-3.
Knäuper V; López-Otin C; Smith B; Knight G; Murphy G
J Biol Chem; 1996 Jan; 271(3):1544-50. PubMed ID: 8576151
[TBL] [Abstract][Full Text] [Related]
14. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity.
Pei D; Weiss SJ
J Biol Chem; 1996 Apr; 271(15):9135-40. PubMed ID: 8621565
[TBL] [Abstract][Full Text] [Related]
15. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases.
Miyamori H; Takino T; Kobayashi Y; Tokai H; Itoh Y; Seiki M; Sato H
J Biol Chem; 2001 Jul; 276(30):28204-11. PubMed ID: 11382769
[TBL] [Abstract][Full Text] [Related]
16. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes.
Toth M; Chvyrkova I; Bernardo MM; Hernandez-Barrantes S; Fridman R
Biochem Biophys Res Commun; 2003 Aug; 308(2):386-95. PubMed ID: 12901881
[TBL] [Abstract][Full Text] [Related]
17. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
18. Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.
Fillmore HL; VanMeter TE; Broaddus WC
J Neurooncol; 2001 Jun; 53(2):187-202. PubMed ID: 11716070
[TBL] [Abstract][Full Text] [Related]
19. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
Imai K; Ohuchi E; Aoki T; Nomura H; Fujii Y; Sato H; Seiki M; Okada Y
Cancer Res; 1996 Jun; 56(12):2707-10. PubMed ID: 8665498
[TBL] [Abstract][Full Text] [Related]
20. Cell membrane-associated MT1-MMP-dependent activation of pro-MMP-2 in A375 melanoma cells.
Banerji A; Chakraborti J; Mitra A; Chatterjee A
J Environ Pathol Toxicol Oncol; 2005; 24(1):3-17. PubMed ID: 15715505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
